Business Description
Shandong Wohua Pharmaceutical Co Ltd
NAICS : 325411
SIC : 2834
ISIN : CNE000001QB8
Share Class Description:
SZSE:002107: Class ACompare
Compare
Traded in other countries / regions
002107.China IPO Date
2007-01-24Description
Shandong Wohua Pharmaceutical Co Ltd is a China-based company specializing in the field of cardio-cerebral vascular medicine. The company's main products consist of Xinkeshu tablets for the treatment of coronary heart disease; Naoxueshu oral liquid, promoting blood circulation by removing blood stasis; Hupo Xiaoshi granules for the treatment of urethral calculus, and Yuandu granules for the treatment of influenza, among others.
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2144.07 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 1353.93 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.92 | |||||
Beneish M-Score | -3.33 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.9 | |||||
3-Year EBITDA Growth Rate | -30.1 | |||||
3-Year EPS without NRI Growth Rate | -29.9 | |||||
3-Year FCF Growth Rate | -4.5 | |||||
3-Year Book Growth Rate | -0.1 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.14 | |||||
9-Day RSI | 28.11 | |||||
14-Day RSI | 31.15 | |||||
6-1 Month Momentum % | -26.26 | |||||
12-1 Month Momentum % | -20.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.35 | |||||
Quick Ratio | 1.88 | |||||
Cash Ratio | 1.54 | |||||
Days Inventory | 227.04 | |||||
Days Sales Outstanding | 34.06 | |||||
Days Payable | 87.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 6.53 | |||||
Forward Dividend Yield % | 6.53 | |||||
5-Year Yield-on-Cost % | 6.53 | |||||
Shareholder Yield % | 6.2 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.81 | |||||
Operating Margin % | 4.26 | |||||
Net Margin % | 4.83 | |||||
FCF Margin % | 16.9 | |||||
ROE % | 5.4 | |||||
ROA % | 3.8 | |||||
ROIC % | 4.78 | |||||
ROC (Joel Greenblatt) % | 10.33 | |||||
ROCE % | 4.72 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 48.38 | |||||
PE Ratio without NRI | 47.2 | |||||
Shiller PE Ratio | 22.76 | |||||
Price-to-Owner-Earnings | 84.12 | |||||
PEG Ratio | 18.88 | |||||
PS Ratio | 2.36 | |||||
PB Ratio | 2.74 | |||||
Price-to-Tangible-Book | 3 | |||||
Price-to-Free-Cash-Flow | 13.66 | |||||
Price-to-Operating-Cash-Flow | 13.45 | |||||
EV-to-EBIT | 43.65 | |||||
EV-to-EBITDA | 43.65 | |||||
EV-to-Revenue | 1.97 | |||||
EV-to-FCF | 12.51 | |||||
Price-to-Projected-FCF | 1.06 | |||||
Price-to-Median-PS-Value | 0.52 | |||||
Price-to-Graham-Number | 2.51 | |||||
Price-to-Net-Current-Asset-Value | 6.34 | |||||
Price-to-Net-Cash | 20.37 | |||||
Earnings Yield (Greenblatt) % | 2.29 | |||||
FCF Yield % | 6.73 | |||||
Forward Rate of Return (Yacktman) % | -0.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Wohua Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 889.542 | ||
EPS (TTM) (Â¥) | 0.08 | ||
Beta | 0.59 | ||
Volatility % | 26.36 | ||
14-Day RSI | 31.15 | ||
14-Day ATR (Â¥) | 0.148115 | ||
20-Day SMA (Â¥) | 4.18 | ||
12-1 Month Momentum % | -20.32 | ||
52-Week Range (Â¥) | 3.2 - 7.22 | ||
Shares Outstanding (Mil) | 577.21 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shandong Wohua Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shandong Wohua Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shandong Wohua Pharmaceutical Co Ltd Frequently Asked Questions
What is Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107)'s stock price today?
The current price of SZSE:002107 is ¥3.87. The 52 week high of SZSE:002107 is ¥7.22 and 52 week low is ¥3.20.
When is next earnings date of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107)?
The next earnings date of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) is .
Does Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) is 6.53% (As of Today), Highest Dividend Payout Ratio of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) was 1.44. The lowest was 0.2. And the median was 0.57. The  Forward Dividend Yield % of Shandong Wohua Pharmaceutical Co Ltd(SZSE:002107) is 6.53%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |